Ignite Creation Date:
2024-05-06 @ 2:47 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04421378
Status:
TERMINATED
Last Update Posted:
2023-09-06
First Post:
2020-06-01
Brief Title:
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Karyopharm Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-01
First Submit QC Date:
June 5 2020
Study First Post Date:
2020-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-31
Last Update Post Date:
2023-09-06
Last Update Post Date Type:
ACTUAL